PCF-VAE:为新的药物设计提供后部无崩变异自编码器
Arun Singh Bhadwal1, Monika Kumari2, Anil Kumar3
1School of Computer Science Engineering and Technology, Bennett University, Plot No. 8-11, Techzone-II, Greater Noida, Uttar Pradesh, 201310, India.
Scientific reports
|October 1, 2025
概括
本研究介绍了PCF-VAE,这是一种新的深度学习方法,通过解决变异自编码器的后部崩来增强分子生成,从而导致更多样化和有效的新型分子结构.
科学领域:
- 人工智能的人工智能
- 化学信息学 化学信息学
- 药物发现 药物发现 药物发现
背景情况:
- 产生具有所需性质的新型分子是复杂的,因为巨大的化学空间和模型限制.
- 变化自编码器 (VAE) 用于 de novo 分子设计,但往往遭受后部崩,限制生成的分子多样性.
- 现有的最先进的方法与后部崩作斗争,阻碍了各种分子结构的生成.
研究的目的:
- 为了研究和减轻VAE后部崩的问题,以进行新的分子设计.
- 开发一种新的方法,减少SMILES表示的复杂性,增强分子多样性.
- 提高产生的分子的有效性,独特性和新性.
主要方法:
- 采用各种生成的VAE来绘制分子结构的地图,并从一个连续的潜空间.
- 引入了一种新的方法,PCF-VAE,以解决后部崩并改善分子生成.
- 在不同多样性级别 (D=1,D=2,D=3) 的MOSES基准指标上评估PCF-VAE表现.
主要成果:
- PCF-VAE显示出高的有效率:98.01% (D=1),97.10% (D=2) 和95.01% (D=3).这些都是PCF-VAE的有效率.
- 实现了100%的独特结构生成和高度的内部多样性 (intDiv: 85.87-89.01%,intDiv2: 85.87-86.33%).
- 产生了93.77% (D=1),94.71% (D=2) 和95.01% (D=3) 的新分子.
结论:
- PCF-VAE有效地减轻后部崩,增强分子多样性和新奇性在新设计中.
- 拟议的方法在分子生成任务中比最先进的方法提供了显著的改进.
- 这项研究为设计具有特定药理和物理化学性质的新分子提供了宝贵的见解.
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
288
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
288
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
1.1K
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Model Approaches for Pharmacokinetic Data: Compartment Models
496
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
496
Estimation of k and VD of Aminoglycosides
185
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
185


